People with diabetes are faced with making over 180 treatment decisions every single day. The constant demand and unpredictability of life with diabetes can be quite a burden when it impacts every area of your life. For many people with diabetes, it is not unusual to become exhausted by the burden of managing diabetes. However it is well-known that being proactive with insulin management can significantly improve A1C and glycemic variability with your diabetes management.
The long-awaited announcement of FDA approval of Omnipod 5 finally came in January 2022. This system is the first automated insulin delivery system that is completely tubeless. Omnipod 5 is a hybrid closed-loop AID (automated insulin delivery device) that is comparable to the current Medtronic and Tandem systems. Here’s what you should know: